Veterinary pharmaceuticals firm Dechra has announced the expansion of its range of products to treat otitis externa with the introduction of Osurnia.
You'll need to
subscribe to unlock this content. Already subscribed? Login?
Become a member for unlimited access
Remove all content restrictions with a membership account. First-year special offer pricing. Cancel any time.
You have read 2/2 free articles this month.
How many members should have access to the subscription?
Monthly
£4.99
5 days free trial
Yearly
£49.99
Save £9.89
5 days free trial
No, thanks
I already have an account
